IBC
IBC today announced the details of its Big Screen programme, taking place in a specially built auditorium designed to IBC’s specifications and featuring the very latest in cinema technology. With the latest Dolby Vision dramatic imaging and Dolby Atmos immersive audio sound installation, the four-day programme examines and demonstrates the hottest topics, themes, and insights surrounding the art, science, and business of cinema - from capture through to exhibition.
As well as being the home of the Big Screen programme, the auditorium will screen in Dolby Vision and Dolby Atmos, Baby Driver , the acclaimed Edgar Wright feature from 2017.
The programme for 2017, which has been shaped by a committee of global industry professionals, is an insightful examination of the future of cinema. From virtual reality in cinema to laser and camera assessments, visitors will get up to speed on evolving technology and how this impacts the business of cinema. Highlighted sessions include:
Future camera and display technologies and applications leading to AV/VR, immersive media and holography – 16 September 11.00 – 12.30 . Known for his work on X-Men , leading cinematographer, VFX supervisor and author David Stump, and Light Field Lab’s Jon Karafin (Alice in Wonderland and Transformers ), light field visionary and motion picture technology innovator, will discuss how content creators can explore and be empowered with these new methods and technologies.
Event cinema on steroids: shooting and delivering HDR and immersive audio alternative content to the Big Screen – 15 September 16.00 – 17.00 . This session will look at sports’ largest global event the UEFA Champions League football final that took place in Cardiff on 3rd June 2017. BT Sport achieved the mammoth task of shooting and broadcasting this event in both HDR and immersive audio live to homes and for the first time to a cinema screening room. The session will screen highlights of the broadcast in the Dolby Vision and Atmos-equipped Big Screen Auditorium. Speakers from BT Sport, Dolby and Event Cinema Association will explore how the boundaries of theatrical and non-theatrical disciplines are merging.
The business of cinema will be explored and debated during the International Business Insights sessions that take place on 18 September. Highlights include:
- Who is your cinema audience in 2017? This session focuses on new and cutting-edge research that examines the movie going behaviours and attitudes of key audience segments – Millennials, families and older adults. Chaired by Patrick von Sychowski, Editor of Celluloid Junkie, with speakers from UNIC, Devicescape and Movio.
- The Digital Journey of a Cinemagoer – exploring how the customer journey is evolving and what the cinema industry needs to do to break through to today’s audiences and drive measureable business results. Speakers come from Vue Netherlands, Nordisk Film Cinemas and Gruvi.
- Innovation and the Big Screen Experience – this session looks at recent innovations such as 4DX and VR and the potential impact on cinema going, including asking whether these new technologies will increase attendance and probability or if they are they short lived novelties.
The Big Screen is also home to hugely popular screenings each year. One of the movies for 2017 will be the Edgar Wright action comedy Baby Driver . Released in June, the film stars Ansel Elgort, Kevin Spacey, Lily James, Jon Hamm and Jamie Foxx. Upon release, the film received critical acclaim and has grossed $166 million worldwide against a production budget of $34 million, becoming Wright's highest-grossing film as a director.
## ENDS ##
About IBC
IBC is the world’s leading media, entertainment and technology show. It attracts 55,000+ attendees from more than 170 countries and combines a highly respected and peer-reviewed conference with an exhibition that showcases more than 1,700 leading suppliers of state of the art electronic media and entertainment technology.
IBC2017 Dates
| Conference: | 14 – 18 September 2017 | ||
| Exhibition: | 15 – 19 September 2017 |
For more information about IBC2017 visit: https://show.ibc.org/
View source version on businesswire.com: http://www.businesswire.com/news/home/20170822005998/en/
Contact:
For further information, please contact:
Louise Wells, Bubble
Communications for IBC
E: louisew@bubbleagency.com
T:
+44 7718 985 252
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
30 Peer-Reviewed Studies Highlight Statistically Significant Health Benefits of Almased16.7.2025 09:15:00 CEST | Press release
Two recent, peer-reviewed clinical studies have found that Almased, a high-protein, low-glycemic meal replacement, delivers significant health benefits ranging from weight loss and improved metabolic health to anti-aging effects and enhanced quality of life. Both reviews synthesize 30 peer-reviewed clinical studies across three decades of scientific research, confirming that Almased is effective and safe for weight reduction, preservation of lean muscle mass, and cardiovascular health. The 2025 review in the American Journal of Biomedical Science & Research highlighted Almased’s efficacy and safety for wide groups of people including individuals seeking weight loss, those with metabolic syndrome or fatty liver, older adults needing to preserve muscle mass, and athletes or healthy-weight individuals who require additional high-quality protein. This review also discusses how Almased’s patented fermentation process produces over 80 bioactive peptides, including 2 times the average daily i
The Future of Connectivity Starts Here: Network X Returns to Paris October 14 - 1616.7.2025 09:00:00 CEST | Press release
Show Reconvenes at Paris Expo Porte de Versailles with Global Representation of Industry Leaders and Telco Experts Network X 2025 - the only event that brings the fixed and mobile markets together - returns to Paris Expo Porte de Versailles October 14 - 16. Built for telecom's top players, this annual show drives business model innovation and monetisation of next-generation fixed, mobile, satellite and transport networks through AI and cloud. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250716595903/en/ Speaker on Headliners Stage at Network X 2024 New to Network X in 2025 are specialty events designed to deliver expert insights on trending topics including Data Center World and two Expo Stages for Fixed-Line and Mobile. More than 5,500 telco network infrastructure professionals will gather alongside 1,500 telcos to learn from six program tracks highlighting the latest advancements in Fibre, Wi-Fi Networks and Services, IP
Skechers AERO Series Opens New Chapter of Technical Running Innovation16.7.2025 09:00:00 CEST | Press release
New Collection Features an Evolution in Design that Cuts Through the Wind for That Aerodynamic Feel on Every Run Skechers Performance opens a new chapter of running innovation with the arrival of the Skechers AERO series. Named for the aerodynamic feel of the design, Skechers AERO represents the latest evolution of technical running shoes from the brand. The collection is engineered to deliver an exhilarating blend of speed, style and comfort to help runners cut through the wind and push beyond their personal bests while logging miles. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250716754749/en/ Introducing the Skechers AERO Series of technical running shoes: Skechers AERO Burst, Skechers AERO Spark, and Skechers AERO Tempo (L-R). “Recently launched in North America and Asia, the AERO Series leverages innovative technologies to elevate our signature comfort that’s now available to runners in Europe,” said Ben Stewart, Vic
4Moving Biotech Enrolls First Patient in Phase 2a Trial of 4P004, a Potential First-in-Class GLP-1 Therapy for Knee Osteoarthritis16.7.2025 07:00:00 CEST | Press release
- First patient enrolled in INFLAM MOTION, a global randomized Phase 2a trial including 129 knee osteoarthritis patients - 4P004 to be evaluated over 3 months for dual efficacy: symptom relief and synovial health improvement via contrast-enhanced MRI - Topline results expected in the second half of 2026 4Moving Biotech (4MB), a spin-off of 4P-Pharma dedicated to developing first-in-class treatments that modify the natural course of knee osteoarthritis (OA), today announced that the first patient has been enrolled in Phase 2a clinical trial, INFLAM MOTION. The study will evaluate 4P004, an intra-articular GLP-1 analog, as a potential first-in-class therapeutic candidate for knee osteoarthritis. INFLAM MOTION is a multicenter, randomized, double-blind, placebo-controlled Phase 2a trial planned to be conducted across Europe, the United States, and Canada. A total of 129 patients worldwide diagnosed with knee OA will be enrolled to evaluate, for the first time in humans, the efficacy of 4P
Belkin Achieves Qi2.2 Certification for Its Upcoming Products, Unlocking the Future of 25W Wireless Charging15.7.2025 19:06:00 CEST | Press release
With Qi2.2 certification, Belkin reinforces its commitment to quality, safety, and performance for the next generation of wireless charging Belkin, a leading consumer electronics brand for over 40 years, today announced it has received official Qi2.2 certification from the Wireless Power Consortium (WPC) for its upcoming products. As one of the first accessory brands to deliver Qi2.2-certified devices, Belkin is helping bring the next generation of wireless charging to market – enabling faster wireless charging speeds, broader compatibility, and improved performance for consumers. Belkin’s close partnership with the WPC since 2015 has been instrumental in bringing these advancements to consumers. As an early adopter and long-time contributor to WPC standards, Belkin was selected as one of a small group of trusted manufacturers to test and certify Qi2.2 products ahead of the broader industry rollout. All Belkin products undergo rigorous safety, quality, and performance testing. The comp
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom